Page last updated: 2024-12-05

acid orange 12

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

acid orange 12: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135465070
CHEMBL ID2028361
SCHEMBL ID2865909
SCHEMBL ID755171
SCHEMBL ID9343017
MeSH IDM0054656

Synonyms (36)

Synonym
ponceau 4g
1934-20-9
nsc 7831
1-phenylazo-2-naphthol-6-sulphonic acid monosodium salt
einecs 217-697-4
crocein orange g
sodium 6-hydroxy-5-phenylazo-2-naphthalenesulphonate
6-hydroxy-5-(phenylazo)-2-naphthalenesulfonic acid, sodium salt
2-naphthalenesulfonic acid, 6-hydroxy-5-(phenylazo)-, monosodium salt
acid orange 12
ccris 7443
unii-i3d360r468
2-naphthalenesulfonic acid, 6-hydroxy-5-(2-phenyldiazenyl)-, sodium salt (1:1)
i3d360r468 ,
AKOS024319597
AKOS015889969
SCHEMBL2865909
ci 15970
sodium 1-(phenylazo)-2-naphthol-6-sulfonate
DTXSID9062069
SCHEMBL755171
CHEMBL2028361
SCHEMBL9343017
mfcd00003912
sodium 6-hydroxy-5-[(e)-phenyldiazenyl]-2-naphthalenesulfonate
J-012523
sodium (e)-6-hydroxy-5-(phenyldiazenyl)naphthalene-2-sulfonate
6-hydroxy-5-(phenylazo)-2-naphthalenesulfonic acid monosodium salt
acidorange12dye
Q27280314
D89333
2-naphthalenesulfonicacid,6-hydroxy-5-(2-phenyldiazenyl)-,sodium salt(1:1)
sodium 6-hydroxy-5-(phenyldiazenyl)naphthalene-2-sulfonate
sodium;6-hydroxy-5-phenyldiazenylnaphthalene-2-sulfonate
sodium 6-hydroxy-5-[(1e)-2-phenyldiazen-1-yl]naphthalene-2-sulfonate
CS-0213841
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (33.33)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (10.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]